Piper Jaffray raises price target

Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Reply New Message

Prev Message Back To Forum Threaded View Next Message

liahall

Rank: President [?]

Points: 1896 [?]

Votes: 20 Score: 4.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Piper Jaffray raises price target

posted on Jun 26, 2013 08:32AM

http://www.theflyonthewall.com/permalinks/entry.php/MNKDid1851165/MNKD-MannKind-price-target-raised-to--from--at-Piper-Jaffray

MannKind price target raised to $8.40 from $6 at Piper Jaffray
Piper Jaffray raised its price target for MannKind shares ahead of the data from the AFFINITY Phase III trials in mid-August. Piper expects positive data to support FDA approval and sees significant upside potential for the stock from a licensing agreement or acquisition. The firm keeps an Overweight rating on MannKind with an increased price target of $8.40.

4 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply